TRT on TikTok: separating real benefits from hype

What did @trt__np actually say?

Vivian, a nurse practitioner specializing in TRT, argued that blood donation is actively harmful for men, calling it a chronic iron drain that mimics low testosterone symptoms. Her core claim: "Men aren't meant to bleed regularly like women are." She also said high red blood cell counts on TRT are primarily caused by untreated sleep apnea, not testosterone itself, and that none of her patients donate blood. The implication throughout is that properly managed TRT should never require therapeutic phlebotomy.

She positions blood donation centers as bureaucratic nuisances and suggests that if your hematocrit is elevated, the real fix is treating sleep apnea, not drawing blood. This is a bold, clinic-driven take that deserves a hard look at what the evidence actually says.

Does the science back this up?

Partially. The iron depletion concern is real but overstated as a universal risk. Hematocrit elevation from TRT is well-documented and not fully explained by sleep apnea alone. The sleep apnea connection is legitimate but incomplete.

Exogenous testosterone stimulates erythropoiesis by suppressing hepcidin and increasing erythropoietin sensitivity, which raises red blood cell mass independent of sleep apnea status. Bachman et al. (2014, Journal of Clinical Endocrinology and Metabolism) confirmed testosterone dose-dependently increases hematocrit in healthy men without sleep apnea. So the claim that elevated RBCs are "because you have sleep apnea" is an oversimplification. Sleep apnea does drive secondary polycythemia, and Gonzalez-Martinez et al. (2016, Sleep Medicine) confirmed the overlap, but attributing all TRT-related erythrocytosis to sleep apnea is not supported.

On iron: a single whole blood donation removes approximately 200-250 mg of iron. For iron-replete men, this is generally recoverable within weeks. The claim that donation chronically causes iron deficiency anemia needs individual context, not a blanket prohibition.

What did they get wrong (or right)?

She got the symptom overlap right. Iron deficiency anemia and hypogonadism do share a frustrating number of symptoms, including fatigue, brain fog, and erectile dysfunction. That part is accurate and actually useful for patients to understand.

Where she goes wrong is the absolutism. Saying "none of my patients donate blood, not one" and framing therapeutic phlebotomy as unnecessary if TRT is "done right" ignores that erythrocytosis is a known, dose-dependent side effect of testosterone therapy that occurs even in well-managed patients. The Endocrine Society's 2018 clinical practice guidelines recommend monitoring hematocrit and reducing dose or using phlebotomy when hematocrit exceeds 54%. That guidance exists for a reason.

Her dismissal of blood donation centers as bureaucratic obstacles is a personal grievance dressed up as clinical advice. Therapeutic phlebotomy performed through a provider is a legitimate management tool. Telling patients broadly "don't donate blood" conflates voluntary donation with medically indicated phlebotomy, which is a real distinction she glosses over entirely.

What should you actually know?

TRT-related erythrocytosis is real, is not always explained by sleep apnea, and sometimes does require intervention. Hematocrit should be checked at baseline and at 3 and 6 months after starting therapy, then annually. If it rises above 54%, that warrants a conversation with your provider about dose adjustment, injection frequency changes, or yes, phlebotomy.

Iron deficiency from repeat phlebotomy is a legitimate concern. Patients who undergo frequent therapeutic phlebotomy should have iron studies monitored. But voluntary blood donation one to two times per year is not automatically dangerous for iron-replete men on TRT. The picture is more nuanced than "don't bleed, ever."

Sleep apnea screening is genuinely important before and during TRT. It is underdiagnosed, it does elevate hematocrit, and it does cause symptoms that look like low testosterone. That part of her message is worth keeping. The rest needs calibration.

• Monitor hematocrit at baseline, 3 months, 6 months, then annually on TRT.
• Hematocrit above 54% should prompt dose review, not just phlebotomy.
• Screen for sleep apnea before attributing all symptoms to low testosterone.
• Iron studies should be checked if therapeutic phlebotomy is frequent.
• Therapeutic phlebotomy and voluntary blood donation are not the same thing clinically.